{"result": "(\"entity\"<|>FLUOXETINA<|>PERSON<|>Fluoxetina is a medication studied for its effectiveness in reducing binge eating and purging behaviors in individuals with eating disorders.)\n##\n(\"entity\"<|>TOPIRAMATO<|>PERSON<|>Topiramato is a medication that decreases uncontrolled eating, body dissatisfaction, and anxiety related to food.)\n##\n(\"entity\"<|>ANOREXIA NERVIOSA<|>EVENT<|>Anorexia nerviosa is a serious eating disorder characterized by restrictive eating and an intense fear of gaining weight.)\n##\n(\"entity\"<|>NUTRICIÓN EN LOS TRASTORNOS DE LA CONDUCTA ALIMENTARIA<|>EVENT<|>Nutrition in eating disorders is a critical area of study that addresses dietary needs and interventions for individuals with eating disorders.)\n##\n(\"entity\"<|>GÓMEZ CANDELA C<|>PERSON<|>Gómez Candela C is an author who contributed to the chapter on nutrition in eating disorders in a medical textbook.)\n##\n(\"entity\"<|>PELEGRINA CORTÉS B<|>PERSON<|>Pelegrina Cortés B is an author who contributed to the chapter on nutrition in eating disorders in a medical textbook.)\n##\n(\"entity\"<|>PALMA MILLA S<|>PERSON<|>Palma Milla S is an author who contributed to the chapter on nutrition in eating disorders in a medical textbook.)\n##\n(\"entity\"<|>TRATADO DE NUTRICIÓN<|>EVENT<|>Tratado de Nutrición is a medical textbook that includes a chapter on nutrition in eating disorders.)\n##\n(\"relationship\"<|>FLUOXETINA<|>ANOREXIA NERVIOSA<|>Fluoxetina is used to treat symptoms associated with anorexia nerviosa<|>7)\n##\n(\"relationship\"<|>TOPIRAMATO<|>ANOREXIA NERVIOSA<|>Topiramato is used to treat symptoms associated with anorexia nerviosa<|>7)\n##\n(\"relationship\"<|>GÓMEZ CANDELA C<|>TRATADO DE NUTRICIÓN<|>Gómez Candela C authored a chapter in the Tratado de Nutrición regarding nutrition in eating disorders<|>8)\n##\n(\"relationship\"<|>PELEGRINA CORTÉS B<|>TRATADO DE NUTRICIÓN<|>Pelegrina Cortés B authored a chapter in the Tratado de Nutrición regarding nutrition in eating disorders<|>8)\n##\n(\"relationship\"<|>PALMA MILLA S<|>TRATADO DE NUTRICIÓN<|>Palma Milla S authored a chapter in the Tratado de Nutrición regarding nutrition in eating disorders<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: IMC 16-16,99 kg/m2                            conductual también tienen buenos resultados. Además de ello, varios fármacos han\n                                   Grave                                               IMC 15-15,99 kg/m2                            demostrado reducir el número de atracones y purgas, siendo la fluoxetina en dosis de\n                                  Extremo                                                 IMC <15 kg/m2                              60 mg uno de los más estudiados. El topiramato también disminuye las ingestas incontro-\n                                                                                                                                     ladas, la insatisfacción corporal, la preocupación por las comidas y la ansiedad.\n         Subtipos de anorexia nerviosa:                                                                                              Referencias:\n                                                                                                                                     • Gómez Candela C, Pelegrina Cortés B, Palma Milla S. Nutrición en los trastornos de la conducta alimentaria. Cap. 33. Tomo V.\n         •  Tipo restrictivo: en los últimos 3 meses, el individuo no ha tenido episodios recurrentes                                  En: Gil Hernández A, Fontana Gallego L, Sánchez de Medina Contreras F, eds. Tratado de Nutrición. 3.ª ed. Madrid: Editorial Médica\n                                                                                                                                       Panamericana; 2017. p. 568-84.\n            de atracones o purgas (vómito autoprovocado o utilización incorrecta de laxantes, diuré-\n            ticos o enemas). Describe presentaciones en las que la pérdida de peso es debida, sobre\n            todo, a la dieta, el ayuno y/o el ejercicio excesivo.                                                           4.7 Miscelánea\n         •  Tipo con atracones/purgas: en los últimos 3 meses, el individuo ha tenido episodios\n            recurrentes de atracones o purgas.\n         La gravedad se basa, en los adultos, en el índice de masa corporal (IMC) actual o, en niños y                         44    Indique cuál de los siguientes enunciados es cierto:\n         adolescentes, en el percentil del IMC. La gravedad puede aumentar para reflejar los síntomas                                A. La isoniacida aumenta los requerimientos de folatos.\n         clínicos, el grado de discapacidad funcional y la necesidad de supervisión. La amenorrea era                                B. El metotrexato aumenta los requerimientos de piridoxina.\n         uno de los criterios diagnósticos en el DSM-IV, pero se ha eliminado en esta nueva clasificación.                           C. La colestiramina aumenta los requerimientos de vitamina D.\n         Referencias:\n\n\n\n         • DSM-5. Manual Diagnóstico y Estadístico de los Trastornos Mentales. Madrid: Editorial Médica Panamericana 2014.           D.  La obstrucción biliar crónica aumenta los requerimientos de vitamina K.\n236                                                                                                                                                                                                                                                            237\n---\n                                                                                                                                                                                                                                                NUTRICIÓN                            4\n\n\n\n         COMENTARIO                                                                                                                                       rias de vitaminas y minerales. Además de ello, no deben contener menos de 50 g de proteí-\n         Las interacciones entre fármacos y nutrientes son un fenómeno complejo en el que es-                                                             nas de alto valor biológico y tampoco menos de 50 g de hidratos de carbono.\n         tán implicados factores dependientes del fármaco y factores dependientes del individuo.                                                          Su duración habitual es entre 8 y 16 semanas, y usadas como fuente única de alimentación pue-\n         Dentro de los fármacos, los más frecuentemente implicados son aquellos con un margen                                                             den producir pérdidas de peso de 1,5 a 2 kg a la semana en mujeres y entre 2-2,5 kg en hombres.\n         terapéutico estrecho (p. ej., warfarina), los que tienen una curva dosis-efecto de gran pen-                                                     Pueden asociar efectos beneficiosos:\n         diente, de forma que pequeños cambios en la dosis producen grandes cambios en el efec-\n         to, o aquellos      que necesitan        una concentración plasmática mantenida para ser eficaces                                                •  Disminución de la hipertensión arterial.\n         (p. ej., antibióticos). Dentro de los factores dependientes del individuo hay que señalar la                                                     •  Disminución de la glucemia y mejoría del control glucémico en pacientes con diabetes\n         edad,    con especial énfasis en los           niños y en los ancianos,           situaciones fisiológicas como                                     tipo 2.\n         el embarazo, y las patologías que sufra el paciente. Entre dichas interacciones destacan:                                                        •  Disminución de niveles de triglicéridos y aumento del HDL colesterol.\n         •  El metotrexato favorece el déficit de ácido fólico por su unión a la dihidrofolato-reductasa.                                                 Como efectos secundarios destacan: mareos, fatiga, caída de cabello y uñas frágiles, es-\n         •  La isoniacida favorece el déficit de vitamina B6, por malabsorción.                                                                           treñ\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>DSM-5<|>ORGANIZATION<|>The DSM-5 is the Diagnostic and Statistical Manual of Mental Disorders, a comprehensive classification of mental health disorders published by the American Psychiatric Association.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital city of Spain, where the DSM-5 was published by Editorial Médica Panamericana.)\n##\n(\"entity\"<|>EDITORIAL MÉDICA PANAMERICANA<|>ORGANIZATION<|>Editorial Médica Panamericana is a publishing company that published the DSM-5 in 2014.)\n##\n(\"entity\"<|>WARFARINA<|>PERSON<|>Warfarina is a medication that has a narrow therapeutic index and is frequently involved in drug-nutrient interactions.)\n##\n(\"entity\"<|>METOTREXATO<|>PERSON<|>Metotrexato is a medication that can lead to a deficiency of folic acid due to its mechanism of action.)\n##\n(\"entity\"<|>ISONIACIDA<|>PERSON<|>Isoniacida is a medication that can cause a deficiency of vitamin B6 due to malabsorption.)\n##\n(\"relationship\"<|>DSM-5<|>EDITORIAL MÉDICA PANAMERICANA<|>Editorial Médica Panamericana published the DSM-5 in 2014<|>8)\n##\n(\"relationship\"<|>WARFARINA<|>METOTREXATO<|>Both Warfarina and Metotrexato are medications that can interact with nutrients, affecting their absorption and efficacy<|>6)\n##\n(\"relationship\"<|>WARFARINA<|>ISONIACIDA<|>Both Warfarina and Isoniacida are medications that can lead to nutrient deficiencies<|>6)\n##\n(\"relationship\"<|>METOTREXATO<|>ISONIACIDA<|>Both Metotrexato and Isoniacida are medications that can cause deficiencies in essential vitamins<|>6)\n<|COMPLETE|>"}]}